Schroeder Theodore R
Insider CIK 1378690 · COLL Director · CADX President, CEO, Director · TSRX Director · HPTX Director · OTIC Director · CDTX Director · NBRV Chief Executive Officer), Director · PHAT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals, I | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 45,122 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 20,500 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 450 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,400 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2025-04-16 | 2025-04-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2025-04-16 | 2025-04-16 | 21,000 | — | $0 | 21,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-12-17 | 2024-12-19 | 20,500 | — | $0 | 20,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2023-01-29 | 2023-01-31 | 431 | $1.50 | $647 | 11,989 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2023-01-06 | 2023-01-10 | 11 | $1.30 | $14 | 12,420 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-12-31 | 2023-01-04 | 5 | $1.89 | $9 | 12,431 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-12-06 | 2022-12-08 | 9 | $2.02 | $18 | 12,436 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-11-30 | 2022-12-02 | 5 | $2.25 | $11 | 12,445 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-11-06 | 2022-11-08 | 10 | $2.24 | $22 | 12,450 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-10-31 | 2022-11-01 | 5 | $2.54 | $13 | 12,460 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-10-06 | 2022-10-11 | 9 | $2.72 | $24 | 12,465 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-09-30 | 2022-10-04 | 5 | $2.08 | $10 | 12,474 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-09-06 | 2022-09-07 | 225 | $0.16 | $36 | 311,977 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-08-31 | 2022-09-01 | 107 | $0.16 | $17 | 312,202 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 239,800 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 119,900 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 239,800 | — | $0 | 239,800 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 119,900 | — | $0 | 119,900 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-08-06 | 2022-08-08 | 225 | $0.18 | $41 | 312,309 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-07-31 | 2022-08-03 | 107 | $0.18 | $19 | 312,534 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-07-06 | 2022-07-07 | 225 | $0.18 | $41 | 312,641 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-06-30 | 2022-07-01 | 107 | $0.18 | $19 | 312,866 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2022-06-21 | 2022-06-23 | 27,500 | — | $0 | 27,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-06-06 | 2022-06-07 | 225 | $0.20 | $45 | 312,973 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-05-31 | 2022-06-02 | 107 | $0.21 | $22 | 313,198 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-05-06 | 2022-05-09 | 225 | $0.26 | $59 | 313,305 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-04-30 | 2022-05-03 | 107 | $0.31 | $33 | 313,530 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-04-06 | 2022-04-08 | 219 | $0.41 | $90 | 313,637 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-03-31 | 2022-04-04 | 104 | $0.42 | $44 | 313,856 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-03-06 | 2022-03-08 | 263 | $0.43 | $113 | 313,960 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-02-28 | 2022-03-02 | 125 | $0.45 | $56 | 314,223 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-02-06 | 2022-02-08 | 263 | $0.48 | $126 | 314,348 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-01-31 | 2022-02-01 | 125 | $0.48 | $60 | 314,611 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-01-29 | 2022-02-01 | 10,766 | $0.45 | $4.8K | 314,736 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2022-01-28 | 2022-02-01 | 119,900 | — | $0 | 119,900 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2022-01-28 | 2022-02-01 | 239,800 | — | $0 | 239,800 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-01-06 | 2022-01-10 | 270 | $0.58 | $157 | 325,502 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-12-31 | 2022-01-04 | 107 | $0.60 | $64 | 325,772 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2021-12-28 | 2021-12-29 | 100,000 | $0.57 | $57.0K | 325,879 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-12-06 | 2021-12-08 | 225 | $0.72 | $162 | 225,879 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-11-30 | 2021-12-02 | 107 | $0.78 | $83 | 226,104 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-11-06 | 2021-11-09 | 225 | $1.33 | $299 | 226,211 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-10-31 | 2021-11-01 | 107 | $1.15 | $123 | 226,436 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-10-06 | 2021-10-08 | 225 | $1.08 | $243 | 226,543 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-09-30 | 2021-10-04 | 107 | $1.19 | $127 | 226,768 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2021-09-14 | 2021-09-15 | 50,000 | $1.13 | $56.5K | 226,875 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-09-06 | 2021-09-08 | 225 | $1.11 | $250 | 176,875 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-08-31 | 2021-09-02 | 107 | $1.06 | $113 | 177,100 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-08-06 | 2021-08-10 | 225 | $1.17 | $263 | 177,207 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-07-31 | 2021-08-03 | 107 | $1.10 | $118 | 177,432 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-07-06 | 2021-07-08 | 225 | $1.27 | $286 | 177,539 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-06-30 | 2021-07-02 | 107 | $1.35 | $144 | 177,764 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2021-06-22 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-06-06 | 2021-06-08 | 225 | $1.34 | $302 | 177,871 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-05-31 | 2021-06-02 | 107 | $1.38 | $148 | 178,096 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-05-06 | 2021-05-10 | 225 | $1.49 | $335 | 178,203 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-04-30 | 2021-05-04 | 107 | $1.78 | $190 | 178,428 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-04-06 | 2021-04-08 | 225 | $1.73 | $389 | 178,535 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-03-31 | 2021-04-02 | 107 | $1.66 | $178 | 181,680 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-03-06 | 2021-04-08 | 225 | $1.79 | $403 | 178,760 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-02-28 | 2021-03-02 | 106 | $2.39 | $253 | 181,787 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-02-06 | 2021-04-08 | 2,695 | $2.90 | $7.8K | 178,985 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-01-31 | 2021-02-02 | 125 | $2.62 | $328 | 181,893 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2021-01-29 | 2021-02-02 | 117,500 | — | $0 | 182,018 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-12-31 | 2021-01-05 | 121 | $2.42 | $293 | 64,518 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-11-30 | 2020-12-01 | 1,211 | $0.43 | $521 | 646,396 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-10-31 | 2020-11-02 | 1,211 | $0.50 | $606 | 647,607 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-09-30 | 2020-10-01 | 1,211 | $0.53 | $642 | 648,818 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-31 | 2020-09-02 | 1,211 | $0.62 | $751 | 650,029 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-07-31 | 2020-08-04 | 1,211 | $0.76 | $920 | 651,240 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-06-30 | 2020-07-02 | 1,211 | $0.67 | $811 | 652,451 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2020-06-25 | 2020-06-25 | 17,500 | — | $0 | 17,500 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2020-06-23 | 2020-06-25 | 17,500 | — | $0 | 17,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-05-31 | 2020-06-03 | 1,211 | $1.14 | $1.4K | 653,662 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2020-05-20 | 2020-05-22 | 8,095 | — | $0 | 8,095 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2020-05-20 | 2020-05-22 | 4,047 | — | $0 | 11,007 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-04-30 | 2020-05-04 | 1,211 | $0.55 | $666 | 648,686 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-03-31 | 2020-04-02 | 1,211 | $0.58 | $702 | 649,897 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-02-28 | 2020-03-03 | 1,211 | $1.35 | $1.6K | 651,108 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2020-02-06 | 2020-02-10 | 687,500 | — | $0 | 687,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2020-02-06 | 2020-02-10 | 343,800 | — | $0 | 646,560 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-01-31 | 2020-02-04 | 16,276 | $1.35 | $22.0K | 302,760 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2019-08-27 | 2019-08-28 | 50,000 | $1.79 | $89.5K | 117,489 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2019-07-25 | 2019-07-25 | 6,748 | — | $0 | 67,489 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2019-06-17 | 2019-06-27 | 11,000 | — | $0 | 11,000 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2019-06-11 | 2019-06-13 | 17,500 | — | $0 | 17,500 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2019-04-25 | 2019-04-29 | 9,414 | — | $0 | 9,414 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2019-04-25 | 2019-04-29 | 4,707 | — | $0 | 6,960 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 163,250 | — | $0 | 163,250 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 429,800 | — | $0 | 429,800 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-07-25 | 2018-07-27 | 850,000 | — | $0 | 850,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-07-25 | 2018-07-27 | 150,000 | — | $0 | 150,000 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2018-06-19 | 2018-06-20 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2018-05-24 | 2018-05-29 | 4,506 | — | $0 | 4,506 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2018-05-24 | 2018-05-29 | 2,253 | — | $0 | 2,253 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2017-06-22 | 2017-06-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2017-06-20 | 2017-07-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2017-05-24 | 2017-05-25 | 19,853 | — | $0 | 19,853 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 9,000 | — | $0 | 9,000 | SEC↗ |
| OTIC Otonomy, Inc. | A Award deriv | 2016-06-21 | 2016-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2016-06-09 | 2016-06-13 | 8,700 | — | $0 | 8,700 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2016-01-22 | 2016-01-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OTIC Otonomy, Inc. | A Award deriv | 2015-08-28 | 2015-09-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2015-06-09 | 2015-06-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 6,800 | $46.00 | $312.8K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer | 2015-05-07 | 2015-05-08 | 3,083 | $46.00 | $141.8K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | U Tender | 2015-05-07 | 2015-05-08 | 617 | $46.00 | $28.4K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2014-08-13 | 2014-08-14 | 6,800 | — | $0 | 6,800 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award | 2014-08-13 | 2014-08-14 | 3,700 | — | $0 | 3,700 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 164,074 | $10.49 | $1.72M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 350,000 | $10.49 | $3.67M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 500,000 | $5.45 | $2.73M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 150,000 | $4.78 | $717.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 200,000 | $5.65 | $1.13M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 400,000 | $7.99 | $3.20M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 100,000 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 510,935 | $12.64 | $6.46M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 400,000 | $8.60 | $3.44M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 400,000 | $14.00 | $5.60M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 35,000 | $4.78 | $167.3K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 307,500 | $14.00 | $4.30M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 12,664 | $14.00 | $177.3K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2014-02-10 | 2014-02-12 | 400,000 | — | $0 | 400,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 15,116 | $5.93 | $89.6K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $8.45 | $101.4K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $5.24 | $62.9K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $10.00 | $120.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 15,000 | $5.73 | $86.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2013-05-21 | 2013-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2013-03-13 | 2013-03-15 | 400,000 | — | $0 | 400,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2012-05-22 | 2012-05-24 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-03-14 | 2012-03-16 | 350,000 | — | $0 | 350,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-03-14 | 2012-03-16 | 164,074 | — | $0 | 164,074 | SEC↗ |